drugset / Trial / NCT06142604

Single Dose Flecainide for Early Sinus Rhythm Conversion of Perioperative Atrial Fibrillation After Noncardiac Surgery

NCT06142604

RandomizedParallel-groupSingle-blindTreatment

Summary

Investigator-initiated pilot study of single dose oral flecainide versus no flecainide for the early conversion of perioperative atrial fibrillation to sinus rhythm after noncardiac surgery.

Timeline

Start
2024-07-01
Primary completion
2025-06-30
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject flecainide Small molecule 300 mg Oral

Indications